bpc-157 adverse events human case report Stable Gastric Pentadecapeptide BPC 157 and Wound Healing The Hidden Risks of BPC‑157:

This condition can cause gait disturbance, weakness, and altered proprioception, potentially leading to abnormal joint loading and secondary musculoskeletal pain

They suggest steering clear of non-prescription use

It is optimized for laboratory preparation compatibility with sensitive research compounds without altering receptor pathway research variables

(Some have theoretical worries that, for instance, BPC-157 might promote the growth of tumor cells.) On the other is an increasingly large and vocal cohort of experts and regular people who feel that the FDA, the pharmaceutical industry, and esteemed scientific institutions are gatekeeping potentially miraculous substances

This may vary from twice weekly to once every 2-4 weeks (source: The basics of treatment It is not understood why certain patients require more frequent B12 treatment